Efficacy and safety Of artemether‑lumefantrine for the treatment Of uncomplicated malaria and prevalence Of Pfk13 and Pfmdr1 polymorphisms After a decade of using artemisinin‑based Combination therapy in mainland Tanzania

Ishengoma, D.S.; Mandara, C.I.; Francis, F.; Talundzic, E.; Lucchi, N.W.; Ngasala, B.; Kabanywanyi, A.M.; Mahende, M.K.; Kamugisha, E.; Kavishe, R.A.; Muro, F.; Mohamed, A.; Mandike, R.; Mkude, S.; Chacky, F.; Paxton, L.; Greer, G.; Kitojo, C.A.; Njau, R.; Martin, T.; Venkatesan, M.; Warsame, M.; Halsey, E.S.; Udhayakumar, V.

MUHAS IR Home
→
School of Public Health and Social Sciences
→
Public Health and Social Sciences - Journals
→
View Item

Efficacy and safety Of artemether‑lumefantrine for the treatment Of uncomplicated malaria and prevalence Of Pfk13 and Pfmdr1 polymorphisms After a decade of using artemisinin‑based Combination therapy in mainland Tanzania

Ishengoma, D.S.; Mandara, C.I.; Francis, F.; Talundzic, E.; Lucchi, N.W.; Ngasala, B.; Kabanywanyi, A.M.; Mahende, M.K.; Kamugisha, E.; Kavishe, R.A.; Muro, F.; Mohamed, A.; Mandike, R.; Mkude, S.; Chacky, F.; Paxton, L.; Greer, G.; Kitojo, C.A.; Njau, R.; Martin, T.; Venkatesan, M.; Warsame, M.; Halsey, E.S.; Udhayakumar, V.

URI: http://dspace.muhas.ac.tz:8080/xmlui/handle/123456789/2406

Date: 2019

Abstract:

The World Health Organization recommends regular therapeutic efficacy studies (TES) to monitor the performance of first and second-line anti-malarials. In 2016, efficacy and safety of artemether-lumefantrine (AL) for the treatment of uncomplicated falciparum malaria were assessed through a TES conducted between April and October 2016 at four sentinel sites of Kibaha, Mkuzi, Mlimba, and Ujiji in Tanzania. The study also assessed molecular markers of artemisinin and lumefantrine (partner drug) resistance.

Show full item record